Kevin Rakin, Director at HISTOGENICS CORP (HSGX), bought 21,146 shares at $11.00 ($124K) on 2014-12-08, disclosed to the SEC on 2014-12-08.
Open-market purchase of $124k HSGX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 9,667 | $0 | 0.0% |
| 2 | $0.76 | 242 | $184 | 0.1% |
| 3 | $11.00 | 4,495 | $49K | 39.9% |
| 4 | $11.00 | 6,742 | $74K | 59.9% |
| Total | $5.85 avg | 21,146 | $124K | 100% |
| Filing → |
| ORMP | SELL | 2022-03-22 | $94K | — | Filing → |
| ORMP | SELL | 2021-09-20 | $886K | — | Filing → |
| OMRI | BUY | 2008-03-28 | $27K | — | Filing → |